hotspot -WSS

hotspot

author：leisure time 2025-09-06 01:37:58 - browse：871

the Federal Trade Commission building and its brown sign — Adobe

A federal judge ordered Wednesday that Novant Health can move forward with its plan to buy two North Carolina hospitals, denying the Federal Trade Commission’s request for an injunction.

The FTC sued to block the deal in January, arguing that it would give Novant control of more than 65% of the region’s inpatient market. The case, one seeking to block nearby hospitals from merging and creating an even more powerful dominant player, is the FTC’s bread and butter. The agency has shied away from challenging cross-market and vertical mergers, but this one is right in its wheelhouse, which makes the setback surprising.

Under the deal, announced early last year, Novant would buy two hospitals in the same county from for-profit Community Health Systems for $320 million. The hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, are only a 25-minute drive from one another. Davis Regional used to be a full-service hospital, but is now a psychiatric hospital. The deal also includes a group of 24 doctors, a majority interest in an endoscopy center, and a holding in a planned surgery center.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Readout LOUD podcast: A CRISPR milestone, biotech mixology

entertainment

focus

WSS

FDA's Woodcock to retire early next year

Public health communication lessons from Covid

Biden jokes that Republicans may impeach him because inflation is starting to cool down

VC firm RA Capital starts a new synthetic biology incubator

Timeline: Special counsel's probe into Trump's handling of classified documents

NYU radiologists take on the challenge of expensive MRI machines

knowledge

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

'The boss' wants server deleted: New allegations emerge in Trump indictment

Affirmative action in medical school literally saved lives

Behind warning on Apellis’s eye drug lies a conflict of interest

Jerome Adams on the need for new antivirals for Covid

Ending health disparities requires full federal government, panel says

Peter Hotez and the public health issue of online harassment

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

In Memoriam: Notable people who died in 2023

As the dark side of IVF slowly comes into focus, even more transparency is needed

explore

Weight loss drug costs may need more research, senator suggests

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Wegovy, Zepbound and weight loss drugs that preserve muscle

VC firm RA Capital starts a new synthetic biology incubator

Trump allegedly attempted to have surveillance video deleted: Special Counsel

Readout LOUD podcast: A CRISPR milestone, biotech mixology

entertainment

focus

Wikipedia

hotspot